Your session is about to expire
← Back to Search
Chemotherapy + Stem Cell Rescue for Neuroblastoma
Study Summary
This trial is testing a new treatment for neuroblastoma that involves two courses of chemotherapy followed by stem cell rescue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is Autologous Stem Cell Infusion a novel approach to therapy and has it been tested before?
"Currently, the active number of investigational trials for Autologous Stem Cell Infusion is a robust 1653 with 388 in Phase 3. Leesburg Virginia has an especially high concentration of clinical studies regarding this therapy; however there are roughly 71730 sites participating globally."
How numerous is the collective of participants involved in this research?
"Indeed, the details located on clinicaltrials.gov confirm that this medical study is currently seeking participants. The research was first announced on June 1st 2016 and has been updated as recently as November 2nd 2022. 12 people need to be recruited from a single clinic for the trial to move forward."
Has Autologous Stem Cell Infusion attained governmental endorsement?
"Autologous Stem Cell Infusion has been assigned a score of 2 on our power scale, due to the limited data regarding its efficacy as it is only in Phase 2 clinical trials. That said, there have been some studies that demonstrate safety when using this medication."
What health benefits are typically associated with Autologous Stem Cell Infusion?
"Autologous Stem Cell Infusion is the primary treatment for those suffering from Merkel cell cancer; however, it has also been successfully used to treat leukemia, initial treatments and prostate cancer."
Are there any vacancies for participants in this trial?
"Affirmative, clinicaltrials.gov offers evidence that this study is accepting participants. Initially posted on June 1st 2016 and recently updated November 2nd 2022, the trial intends to recruit 12 individuals from a single site."
Share this study with friends
Copy Link
Messenger